Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amgen, Anheart, Aslan, Astrazeneca, Blue Lake, Cstone, Cyanvac, Ena Respiratory, Genfleet, Hanmi, Harbour Biomed, Hua Medicine, I-Mab, Innovent Biologics, JW, Kyowa Kirin, Laurent, Merck, Nrx, Pfizer, Pulmotect, RDIF, Regeneron, Ribomic, Ridgeback, Roche, Senhwa, Todos Medical, Trevena, VBI Vaccines.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Appili, Astex, Betterlife, Clover, Codagenix, Corvus, Enlivex, Gilead Sciences, Hightide, Hutchmed, Johnson & Johnson, Kyowa Kirin, Moderna, Newsoara, Otsuka, Phoxbio, Reven, Rhizen, SAB, Valneva, Zenith Epigenetics.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Aicuris Anti-Infective Cures, Aivita Biomedical, Appili, Arca, Astellas, Astrazeneca, Atyr, Biontech, Biophytis, Calcimedica, Coherus, Cstone, Daiichi Sankyo, Edesa, Eiger, Eqrx, Gritstone, Hutchmed, Jemincare, Junshi, Pangu, Pfizer, Pharming, Providence, Redhill, Rottapharm, Sumitomo Dainippon, Takis, Urovant Sciences, Valneva, Vicore.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adlai Nortye, Ascentage, Ascletis, Astrazeneca, Azurrx, Azurx, Cstone, Cytodyn, Edigene, Excalibur Medicines, Gannex, Hutchmed, Innovent Biologics, Kintor, Novavax, Senhwa, Sorrento, Swedish Orphan Biovitrum, Telix.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adamis, Amarin, Code, Connect, Curevac, Daiichi-Sankyo, Exevir, Gennova, Glaxosmithkline, HDT, Immutep, Merck, Nrx, Pfizer, Pharmaxis, Quantum Leap Healthcare Collaborative, Ridgeback, Rigel, Senhwa, SK Bioscience, Takeda, Tevogen.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Affibody, Airway, Ascletis, Awakn Life Sciences, Bavarian Nordic, Bridgebio, Brii, Clarity, Edesa, Emergent Biosolutions, Eom, Everest Medicines, FSD, Hepagene, Hutchmed, Inmagene, Janssen Research & Development, Lianbio, Meiji Seika, Novavax, Noxopharm, Oncotelic, Pardes, Reistone, Senhwa, Turn.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amerimmune, Astrazeneca, Biophytis, Coherus, Exevir, Histogen, Innocare, Innovent, Junshi, Kyowa Kirin, Mei, Nrx, Senhwa, Telix, Tiziana Life Sciences, Transcenta, Zhaoke Ophthalmology.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Atea, Athersys, Azurrx, Bavarian Nordic, Biontech, Daiichi Sankyo, Gigagen, I-Mab, Immvira, Innovation, Innovent, Lynk, Nrx, Opthea, Pfizer, Sinovac, Valneva.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akston, Brii, Eli Lilly, Humanigen, Immutep, Incyte, Jacobio, Kiniksa, Lumosa, Novavax, Pharmaxis, RDIF, Stemedica Cell Technologies, Takeda, Telix, Vanda.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Astrazeneca, Beigene, China Oncology Focus, Clarity, Daewoong, Eccogene, Effector, Entasis, GNT Biotech & Medicals, Hutchmed, Kintor, Lee’s Pharmaceutical Holdings, Newsoara, Palisade, RDIF, Sorrento, Trevena, Zai Lab.